Table 4.
Subsequent analysis of clinical samples of 20 patients with initial RT-PCR-positive nasopharyngeal aspirates and antibody seroconversion to SARS-associated coronavirus
Time after onset of symptoms (days; n=20) |
|||||
---|---|---|---|---|---|
10 | 13 | 16 | 19 | 21 | |
Sample (positivity rate) | |||||
Nasopharyngeal aspirate | 19 (95%) | 18 (90%) | 18 (90%) | 15 (75%) | 9 (47%)* |
Stool | 20 (100%) | 20 (100%) | 19 (95%) | 12 (80%)† | 10 (67%)† |
Urine | 10 (50%) | 9 (45%) | 7 (35%) | 6 (30%) | 4 (21%)* |
in 19 patients.
In 15 patients